title: Treatment of invasive pulmonary aspergillosis in severely neutropenic children with malignant disorders using liposomal amphotericin B (AmBisome), granulocyte colony-stimulating factor, and surgery: report of five cases.
abstract: Five children with malignancies developed invasive pulmonary aspergillosis during chemotherapy-induced neutropenia. All patients were treated with liposomal amphotericin B and human recombinant granulocyte colony-stimulating factor. Two patients did not recover from bone marrow aplasia and died from organ-infiltrating fungal invasion. Two patients who recovered from bone marrow aplasia survived after surgery of the pulmonary lesions. The fifth patient had a complete resolution of invasive pulmonary aspergillosis after neutrophil recovery without surgical intervention. We conclude that not only the antifungal treatment but also the recovery of granulocytes are important in localizing invasive forms of Aspergillus infections in patients with profound immunosuppression.
authors.affiliation: Division of Hematology/Oncology, University Children's Hospital Graz, Austria.
authors.forename: H J
authors.initials: HJ
authors.lastname: Dornbusch
authors.forename: C E
authors.initials: CE
authors.lastname: Urban
authors.forename: H
authors.initials: H
authors.lastname: Pinter
authors.forename: G
authors.initials: G
authors.lastname: Ginter
authors.forename: R
authors.initials: R
authors.lastname: Fotter
authors.forename: H
authors.initials: H
authors.lastname: Becker
authors.forename: T
authors.initials: T
authors.lastname: Miorini
authors.forename: C
authors.initials: C
authors.lastname: Berghold
mesh_terms: D000293:Adolescent; D000666:Amphotericin B / Q000008:administration & dosage*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000935:Antifungal Agents / Q000008:administration & dosage*; D001228:Aspergillosis / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D002648:Child; D002675:Child, Preschool; D004337:Drug Carriers; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage*; D006801:Humans; D008081:Liposomes; D008172:Lung Diseases, Fungal / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D008297:Male; D009369:Neoplasms / Q000150:complications*; D009503:Neutropenia / Q000150:complications*
chemical_list: D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D004337:Drug Carriers; D008081:Liposomes; C068538:liposomal amphotericin B; D016179:Granulocyte Colony-Stimulating Factor; D000666:Amphotericin B